BBR Partners’s Tourmaline Bio TRML Stock Holding History

BBR Partners’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,000	Closed	-$717K	–	287
2025 Q3	$717K	Hold	15,000	–	–	0.04%	127
2025 Q2	$240K	Buy	15,000 +5,000	+50%	+$81K	0.01%	208
2025 Q1	$152K	Buy	+10,000	New	+$160K	0.01%	226

BBR Partners's TRML Position: Q4 2025 in Review

BBR Partners sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 15,000 shares — an estimated $717K sold.

BBR Partners first reported a position in TRML in Q1 2025 and held it in 3 quarters. The position peaked at $717K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

BBR Partners reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
BBR Partners sold 15,000 Tourmaline Bio shares in Q4 2025, an estimated $717K.
BBR Partners first reported a position in Tourmaline Bio in Q1 2025 and held it in 3 quarters.
BBR Partners's Tourmaline Bio position peaked at $717K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on BBR Partners's 13F filing for Q4 2025, filed 11 Feb 2026.